Latest Conference Articles

Stay up to date on the latest oncology and nursing conferences.

Patients With Advanced Prostate Cancer on Relugolix Experience Manageable Toxicity Levels

Patients With Advanced Prostate Cancer on Relugolix Experience Manageable Toxicity Levels

May 18th 2022, 2:00pm

Relugolix, an oral gonadotropin-releasing hormone receptor antagonist, demonstrated a manageable toxicity profile for patients with advanced prostate cancer.

Patricia Jakel Comments on Combating Burnout in the Acute Care Setting

Patricia Jakel Comments on Combating Burnout in the Acute Care Setting

May 17th 2022, 6:00pm

ONS Annual Congress

Patricia Jakel, RN, MN, AOCN, discusses burnout and compassion fatigue in acute oncology care.

Patients With Metastatic Urothelial Carcinoma Achieve Superior Survival After Experiencing irAEs With Pembrolizumab

Patients With Metastatic Urothelial Carcinoma Achieve Superior Survival After Experiencing irAEs With Pembrolizumab

May 17th 2022, 2:00pm

In patients receiving immune checkpoint inhibition to treat their metastatic urothelial carcinoma, immune-related adverse effects may serve as a prognostic marker for progression-free and overall survival.

Regardless of Prior Local Treatment, Patients With mHSPC Achieve Improved Long-Term Survival With Enzalutamide Plus ADT

Regardless of Prior Local Treatment, Patients With mHSPC Achieve Improved Long-Term Survival With Enzalutamide Plus ADT

May 16th 2022, 5:51pm

A post-hoc analysis of the phase 3 ARCHES found enzalutamide plus androgen deprivation therapy to be an effective treatment for patients with metastatic hormone-sensitive prostate cancer, no matter their history of prior local therapy.

Vitamin C Increases Chemotherapy Responses in Cisplatin-Ineligible Patients With Muscle-Invasive Bladder Cancer

Vitamin C Increases Chemotherapy Responses in Cisplatin-Ineligible Patients With Muscle-Invasive Bladder Cancer

May 16th 2022, 1:41pm

Patients with locally advanced muscle invasive bladder cancer may experience superior benefit from gemcitabine and carboplatin if the chemotherapy is co-administered with vitamin c.

Entrectinib Generates Favorable Outcomes in NTRK Fusion+ Breast Cancer

Entrectinib Generates Favorable Outcomes in NTRK Fusion+ Breast Cancer

May 14th 2022, 3:00pm

Entrectinib elicited encouraging responses in patients with breast cancer that harbors NTRK fusions, according to updates from the phase 2 STARTRK-2 trial.

Investigational RNA Interference Therapy, ARO-HIF2, Yields Encouraging Phase 1 Results in Clear Cell RCC

Investigational RNA Interference Therapy, ARO-HIF2, Yields Encouraging Phase 1 Results in Clear Cell RCC

May 12th 2022, 6:00pm

Patients with clear cell renal cell carcinoma experienced reduced levels of hypoxia inducible factor-2 alpha expression following treatment with ARO-HIF2.

Kate Sandstrom on Ensuring Patient Follow-Up With Radiation Oncology Teams

Kate Sandstrom on Ensuring Patient Follow-Up With Radiation Oncology Teams

May 11th 2022, 6:00pm

ONS Annual Congress

Kate Sandstrom, MSN, APRN-BC, AOCN, discusses the importance of including the radiation oncology team in a patient’s long-term care plan.

Oncology Nurses Drastically Reduce Central Line Infection Incidences Through Peer-to-Peer Observation Strategy

Oncology Nurses Drastically Reduce Central Line Infection Incidences Through Peer-to-Peer Observation Strategy

May 11th 2022, 2:00pm

Oncology nurses at the 2022 ASTCT Meeting shared how a peer-to-peer observation and validation tool helped decrease central line-associated bloodstream infections by 68%.

Study Seeks to Identify Connection Between Cognitive function and Anxiety In Patients Receiving Chemotherapy

Study Seeks to Identify Connection Between Cognitive function and Anxiety In Patients Receiving Chemotherapy

May 10th 2022, 7:02pm

ONS Annual Congress

Unrelieved stress may contribute to cancer-related cognitive impairment and anxiety in patients undergoing chemotherapy.